GLIOMAS
Clinical trials for GLIOMAS explained in plain language.
Never miss a new study
Get alerted when new GLIOMAS trials appear
Sign up with your email to follow new studies for GLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug nivolumab tested against recurrent brain tumors
Disease control CompletedThis phase 2 trial tested the drug nivolumab (Opdivo) in 35 adults with recurrent or progressive IDH mutant gliomas (a type of brain tumor) that had been previously treated with chemotherapy. The main goal was to see if the drug could shrink tumors. The study is now complete.
Matched conditions: GLIOMAS
Phase: PHASE2 • Sponsor: Fabio Iwamoto, MD • Aim: Disease control
Last updated Jun 22, 2026 11:58 UTC
-
Brain cancer chemo delivered directly: a safety first
Disease control CompletedThis early-stage study tested whether it is safe to deliver the chemotherapy drug topotecan directly into the brain over several days for people with recurrent high-grade gliomas (a type of aggressive brain cancer). Five participants received the treatment through a special infus…
Matched conditions: GLIOMAS
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC
-
450 brain tumor patients reveal key survival clues
Knowledge-focused CompletedThis study looked back at 450 people who had surgery for a rare type of brain tumor (cerebellar glioma). Researchers wanted to see if where the tumor was located and its genetic makeup could predict how much of the tumor could be safely removed and how long patients lived. The go…
Matched conditions: GLIOMAS
Sponsor: West China Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC